Teladoc Health Makes A1C Testing Easier for Members with Diabetes
At-Home Testing Improves Diabetes Care & Control for Individuals, Providers & Payers Alike PURCHASE, NY, Aug. 10, 2022 (GLOBE NEWSWIRE)...
Mental Health
Jack.org and Born This Way Foundation Celebrate Be There Certificate During Lady Gaga’s The Chromatica Ball Summer Stadium Tour Stop in Toronto
The Celebration Comes Just as Over 8,000 People Complete the Be There Certificate, a Free Online Course For Peer-to-Peer Mental...
Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE®, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis
Data from the Phase 3 SPIRIT program showed MYFEMBREE reduced menstrual pain and non-menstrual pelvic pain in premenopausal women with...
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on...
American Nurses Association Calls for a Swift and Coordinated Response to Contain the Monkeypox Outbreak
A widespread outbreak of monkeypox will be yet another stressor on the nursing professionSilver Spring, MD, Aug. 05, 2022 (GLOBE...
Addiction Medicine Doctor Tampa, Florida – Dr. Hardeep Singh Named to Tampa Magazines’ 2022 Top Doctors List
Tampa, Aug. 05, 2022 (GLOBE NEWSWIRE) -- The team at Turning Point of Tampa is proud to congratulate Dr. Hardeep...
Additional Analyses of CRN04894 Preclinical and Phase 1 Results to be Presented at the 10th International Congress of Neuroendocrinology
SAN DIEGO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that Peter J. Trainer, M.D.,...
BrainsWay to Report Second Quarter Financial Results on August 10, 2022
BURLINGTON, Mass. and JERUSALEM, July 27, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
COMPASS Pathways plc to announce second quarter 2022 financial results on 4 August 2022
LONDON, July 26, 2022 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating...
U.S. Patent Grant to Strengthen Small Pharma’s DMT Patent Strategy With Injectable Formulation
Key U.S. patent protection on injectable delivery of DMT in lead programs SPL026 and SPL028 LONDON, July 26, 2022 (GLOBE...
Entourage Expands Medical Offerings with Launch of New Services and Products
Starseed signs with HelloMD’s telehealth network to support high volume of patient consultations Debuts customized patient treatment plans which could...
Steven E. Hyman, M.D., Appointed to Cyclerion Therapeutics’ Board of Directors
Renowned neuroscience leader to further long-term clinical research strategy and external collaborationsCAMBRIDGE, Mass., July 26, 2022 (GLOBE NEWSWIRE) -- Cyclerion...
Neuronetics and Alleviant Health Centers Announce Exclusive Partnership
Partnership Will Bring Non-drug NeuroStar® Advanced Therapy for Mental Health to Thousands More Patients MALVERN, Pa., July 25, 2022 (GLOBE...
CloudMD Finalizes Review and Settlement of the VisionPros Acquisition
VANCOUVER, British Columbia, July 22, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH)...
VitalHub Corp. Announces Results of Annual General and Special Meeting of Shareholders
TORONTO, July 22, 2022 (GLOBE NEWSWIRE) -- VITALHUB CORP. (TSX: VHI) (the “Company” or “VitalHub”) today reported a summary of...
XIL Health Ranks No. 35 in the 2022 Top 50 Inspiring Workplaces in North America Award
The St. Louis-based healthtech company offers benefits like paid parental leave, profit sharing and mental health daysST. LOUIS, July 21,...
Neuronetics to Report Second Quarter 2022 Financial and Operating Results and Host Conference Call
MALVERN, Pa., July 19, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on...
COMPASS Pathways appoints Kabir Nath as Chief Executive Officer
Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access...
Impel Pharmaceuticals Announces First Patient Dosed in Phase 2a Study Evaluating INP105 to Treat Acute Agitation in Adolescents With Autism Spectrum Disorder (ASD)
CALM 201 Study to Explore the Safety and Efficacy of Single 5mg-Dose INP105 Compared to Placebo in Quickly Reducing Agitation...
NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of Anxious Depression
Indication demonstrates NeuroStar TMS safety and efficacy in improving anxiety symptoms in depressed patientsMALVERN, Pa., July 19, 2022 (GLOBE NEWSWIRE)...